保险类型与地区贫困程度与肌层浸润性膀胱癌患者总体死亡率升高相关
研究基于宾夕法尼亚州癌症登记处2010至2016年确诊的2597例非转移性肌层浸润性膀胱癌患者,分析地区社会经济地位、城乡居住地和保险类型与总体及癌症特异性死亡率的关系。多变量分析显示,联邦医疗保险(HR 1.15)、医疗补助(HR 1.38)、ADI第3四分位(HR 1.16)和ADI第4四分位(HR 1.21)是总体死亡率升高的独立预测因素(均P < 0.05)。女性及接受非标准治疗与总体死亡率和膀胱癌特异性死亡率升高相关;非西班牙裔白人 vs 非白人、城市 vs 大城镇 vs 农村之间总体及癌症特异性生存均无显著差异。
要点
- 联邦医疗保险(HR 1.15)和医疗补助(HR 1.38)与总体死亡率升高独立相关(均P < 0.05)。
- ADI第3四分位(HR 1.16)和第4四分位(HR 1.21)与总体死亡率升高独立相关(均P < 0.05)。
- 农村居住地与非转移性肌层浸润性膀胱癌总体及癌症特异性生存无显著差异。
核心结论
- 较低社会经济地位以及联邦医疗保险和医疗补助保险与总体死亡率风险升高相关,而农村居住地不是显著因素。
- 作者认为实施公共卫生项目可能有助于缩小低社会经济地位高危人群的死亡率差距。
研究设计与样本
- 利用宾夕法尼亚州癌症登记处识别2010至2016年确诊的2597例非转移性肌层浸润性膀胱癌患者。
- 以地区贫困指数(ADI)作为社会经济地位的替代指标,以城乡通勤区代码分类城市、大城镇和农村社区,ADI以四分位数报告,第4四分位代表最低社会经济地位。
- 拟合多变量logistic回归和Cox模型评估上述社会决定因素与总体及癌症特异性生存的关系,并校正年龄、性别、种族、分期、治疗、城乡分类、保险和ADI。
主要发现
- 多变量分析中,联邦医疗保险(HR 1.15)、医疗补助(HR 1.38)、ADI第3四分位(HR 1.16)和ADI第4四分位(HR 1.21)是总体死亡率升高的独立预测因素(均P < 0.05)。
- 女性及接受非标准治疗与总体死亡率和膀胱癌特异性死亡率升高相关。
- 非西班牙裔白人 vs 非白人、城市 vs 大城镇 vs 农村之间总体及癌症特异性生存均无显著差异。
临床怎么用
- 作者认为实施公共卫生项目可能有助于缩小低社会经济地位高危人群的死亡率差距。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the association of area-level socioeconomic status, rural-urban residence, and type of insurance with overall and cancer-specific mortality among patients with muscle-invasive bladder cancer. METHODS: Using the Pennsylvania Cancer Registry, which collects demographic, insurance, and clinical information on every patient with cancer within the state, we identified all patients diagnosed with non-metastatic muscle-invasive bladder cancer between 2010 and 2016 based on clinical and pathologic staging. We used the Area Deprivation Index (ADI) as a surrogate for socioeconomic status and Rural-Urban Commuting Area codes to classify urban, large town, and rural communities. ADI was reported in quartiles, with 4 representing the lowest socioeconomic status. We fit multivariable logistic regression and Cox models to assess the relationship of these social determinants with overall and cancer-specific survival adjusting for age, sex, race, stage, treatment, rural-urban classification, insurance and ADI. RESULTS: We identified 2597 patients with non-metastatic muscle-invasive bladder cancer. On multivariable analysis, Medicare (hazards ratio [HR] 1.15), Medicaid (HR 1.38), ADI 3 (HR 1.16) and ADI 4 (HR 1.21) were independent predictors of greater overall mortality (all P < 0.05). Female sex and receipt of non-standard treatment were associated with increased overall mortality and bladder cancer-specific mortality. There was no significant difference in both overall and cancer-specific survival between patients who were non-Hispanic White compared to non-White or between those from urban areas, large towns, or rural locations. CONCLUSION: Lower socioeconomic status and Medicare and Medicaid insurance were associated with a greater risk of overall mortality while rural residence was not a significant factor. Implementation of public health programs may help reduce the gap in mortality for low SES at-risk populations.
引用
- Miller DT, Sun Z, Grajales V, et al. Insurance Type and Area Deprivation Are Associated With Worse Overall Mortality for Patients With Muscle-invasive Bladder Cancer. Urology. 2023. PMID: 37028521. doi:10.1016/j.urology.2023.02.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。